SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Carvana Co. is a holding company and an eCommerce platform, which engages in the buying and selling of used cars. The company was founded by Ernest Garcia, III, Benjamin Huston and Ryan Keeton in 2012 and is headquartered in Tempe, AZ.

Carvana Co. - Ordinary Shares - Class A

Carvana Co.

Carvana is trending with high volatility following its earnings report, where an Adjusted EBITDA miss and concerns over profits heavily reliant on non-cash benefits are driving intense community discussion regarding accounting quality and allegations of related-party dealings.

Walmart, Inc. engages in the retail and wholesale business. The company offers an assortment of merchandise and services at everyday low prices. It operates through the following business segments: Walmart U.S., Walmart International, and Sam's Club. The Walmart U.S. segment operates as a mass merchandiser of consumer products, operating under the Walmart and Walmart Neighborhood Market brands, including walmart.com. The Walmart International segment includes operations of wholly-owned subsidiaries in Canada, Chile, China, and Africa, and majority-owned subsidiaries in India, as well as Mexico and Central America. The Sam's Club segment manages membership-only warehouse clubs and operates samsclub.com. The company was founded by Samuel Moore Walton and James Lawrence Walton on July 2, 1962 and is headquartered in Bentonville, AR.

Walmart Inc

Walmart's robust quarterly performance is currently overshadowed by a cautious long-term profit outlook, sparking extensive community debate over its elevated valuation. Investors are actively discussing whether the conservative guidance signals broader economic pressures or is offset by the company's new share repurchase program and increased dividend.

Klarna Group Plc is a global digital bank and flexible payments provider. It operates through an AI-powered payments and commerce network that empowers people to pay smarter, with a mission to be available everywhere, for everything. The company was founded by Gustav Erik Niklas Adalberth, Karl Anders Victor Jacobsson, and Sebastian Marcin Siemiatkowski in 2005 and is headquartered in London, the United Kingdom.

Klarna Group plc

Klarna is a major talking point ahead of its upcoming earnings, with the community weighing strategic tech integrations and a potential credit card rate cap against ongoing lawsuits and a significant insider share lock-up expiration.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio (IBRX) is experiencing a significant surge following the European Commission's conditional marketing authorization for its Anktiva bladder cancer immunotherapy, expanding its global reach to 33 countries and intensifying community speculation about a massive short squeeze. Investors are actively discussing the company's rapid international expansion, including recent Saudi approvals and upcoming developments hinted at by Dr. Pat, believing Anktiva's broad potential could drive substantial future growth and further pressure short positions.

Figma, Inc. is an AI-powered design platform that enables seamless collaboration across the entire product development lifecycle. Its products include FigJam, Figma Slides, Figma Design, Figma Draw, Dev Mode, Figma Sites, Figma Buzz and Figma Make. The company was founded by Dylan Joseph Field and Evan Darrow Wallace in 2012 and is headquartered in San Francisco, CA.

Figma Inc. - Ordinary Shares - Class A

Figma

Figma is trending after reporting better-than-expected financial results and strong future guidance, challenging the narrative that AI will replace traditional software. This strong performance is leading many in the community to believe the stock is undervalued and fueling speculation about a potential short squeeze.

First Majestic Silver Corp. engages in the production, development, exploration and acquisition of mineral properties. It owns and operates producing mines in México including the La Encantada Silver Mine, La Parrilla Silver Mine, San Martin Silver Mine, La Guitarra Silver Mine, Del Toro Silver Mine, Santa Elena Silver & Gold Mine, and San Dimas Silver & Gold Mine. The company was founded by Keith Neumeyer on September 26, 1979 and is headquartered in Vancouver, Canada.

First Majestic Silver Corporation

First Majestic Silver is trending on the back of its strong earnings report, revealing record revenue and treasury, which is driving community optimism for significant growth amid ongoing discussions about undervaluation and market dynamics in the silver sector.

DoorDash, Inc. engages in the design, development, and operation of a food delivery and logistics platform. It serves consumers in the United States, Canada, and Australia. The company was founded by Andy Fang, Tony Xu, Stanley Tang, and Evan Moore on January 12, 2013 and is headquartered in San Francisco, CA.

DoorDash Inc - Ordinary Shares - Class A

DoorDash is experiencing significant market attention and community debate following its Q4 earnings; despite mixed results and a cautious Q1 outlook, the stock saw a notable surge, leading to discussions about the company's strong underlying Gross Order Volume and strategic investments versus concerns over valuation and conflicting analyst price target adjustments.

Etsy, Inc. engages in the operation of an online marketplace. It offers handmade products such as shoes, clothing, bags, and accessories. It operates through the following segments: Etsy, Reverb, and Depop. The company was founded in 2005 and is headquartered in New York, NY.

Etsy Inc

Etsy is surging after reporting strong Q4 earnings and authorizing a significant share buyback, alongside the strategic sale of its Depop marketplace to eBay for $1.2 billion. The community is actively debating whether this divestment is a smart move to refocus on its core business or a loss given the original acquisition cost, fueling conversation around the company's future direction in the evolving e-commerce landscape.

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Hims & Hers Health Inc - Ordinary Shares - Class A

Hims & Hers Health Inc

Hims & Hers Health is trending following its acquisition of Eucalyptus, igniting community debate between those optimistic about global expansion and a potential short squeeze, and others worried about the deal's valuation amidst ongoing regulatory and legal challenges.

Lemonade, Inc. is a holding company, which engages in the provision of insurance services. The firm's products include renters and homeowners insurance, and pet insurance. It offers insurance coverage under the homeowners multi-peril, inland marine, and general liability lines of business. The company was founded by Daniel Asher Schreiber and Shai Wininger on June 17, 2015 and is headquartered in New York, NY.

Lemonade Inc

Lemonade is seeing active discussion following a strong earnings report that highlighted accelerating growth, improved underwriting, and narrowing losses, boosting confidence in its trajectory. Community excitement is also fueled by its innovative offer of a substantial insurance discount for Tesla FSD users, leading to anticipation of market expansion and a potential short squeeze.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$CAPR Keeping an eye on this Monday. Trending on ST. There are 3 places I would average in an entry, if I decided to do that. I would look at a position over the 21 (orange line), over the 50 (red line), and trending into that gap. I would split my entry into 3 pieces because the 21 and 50 are major moving averages. Each could be resistance, and it could fail at those levels. However, if there is a big catalyst, then I would weigh my entries differently. On my watchlist with a 6.75 alert

Jeremy Jacob

Steve D

Stonksgoup

Gus Monson

Oliver

Fritz Franz

Maxstockswins

Charlie Barry

Aris

StockTwits Web

Capricor Therapeutics Inc

 Keeping an eye on this Monday. Trending on ST. There are 3 places I would average in an entry, if I decided to do that. I would look at a position over the 21 (orange line), over the 50 (red line), and trending into that gap. I would split my entry into 3 pieces because the 21 and 50 are major moving averages. Each could be resistance, and it could fail at those levels. However, if there is a big catalyst, then I would weigh my entries differently. On my watchlist with a 6.75 alert

Amazon.com Inc

Marvell Technology Inc

Super Micro Computer Inc

Advanced Micro Devices Inc

Digital Turbine Inc

Cleanspark Inc

Hut 8 Corp

John (aka Dojidad)

NuCana plc

Elite Education Group International Ltd

Fractyl Health Inc.

TVanda00

@TVanda00 That&#39;s a huge gap! It won&#39;t automatically fill it, but that would be an 80% gain. Gaps going down are like escalators and filling them are like stairs. Anyway, if this starts gaining momentum, like the 5-day increasing space above the 10-day, and if volume kicks in, there could be a good opportunity here on $GUTS. I don&#39;t know what that drop was, but it would have to gain probably 10% with volume before I would take a position. Thanks for the heads up. I have an alert set @ 1.10 just to see what the chart looks like.

 That's a huge gap! It won't automatically fill it, but that would be an 80% gain. Gaps going down are like escalators and filling them are like stairs. Anyway, if this starts gaining momentum, like the 5-day increasing space above the 10-day, and if volume kicks in, there could be a good opportunity here on 

. I don't know what that drop was, but it would have to gain probably 10% with volume before I would take a position. Thanks for the heads up. I have an alert set @ 1.10 just to see what the chart looks like.

@dojidad @TVanda00  • Dilution august 2025: New shares + warrants = more supply; existing holders see their stake diluted and future earnings per share/ownership are worth less.
 • Uncertainty over financial health / burn: Losses are increasing, cash is limited; investors worry about how long the company can keep going without another cash raise.
 • Technical / market momentum: Once the dilution announcement hit, traders and algorithms seemed to accelerate the sell-off. After a public offering at discount, many biotech stocks see sharp negative reactions.
 • Mismatch between positive long-term clinical milestones vs short-term financial pain: The data was good, but the market often reacts more strongly to what impacts stock immediately (cash, dilution, near-term expenses) than to future outcomes.

StockTwits for iOS

  • Dilution august 2025: New shares + warrants = more supply; existing holders see their stake diluted and future earnings per share/ownership are worth less.
 • Uncertainty over financial health / burn: Losses are increasing, cash is limited; investors worry about how long the company can keep going without another cash raise.
 • Technical / market momentum: Once the dilution announcement hit, traders and algorithms seemed to accelerate the sell-off. After a public offering at discount, many biotech stocks see sharp negative reactions.
 • Mismatch between positive long-term clinical milestones vs short-term financial pain: The data was good, but the market often reacts more strongly to what impacts stock immediately (cash, dilution, near-term expenses) than to future outcomes.